Letter
Nature 440, 1222-1226 (27 April 2006) | doi:10.1038/nature04695; Received 13 January 2006; Accepted 2 March 2006
Lysyl oxidase is essential for hypoxia-induced metastasis
Janine T. Erler1, Kevin L. Bennewith1, Monica Nicolau2, Nadja Dornhöfer4, Christina Kong3, Quynh-Thu Le1, Jen-Tsan Ashley Chi5, Stefanie S. Jeffrey2 and Amato J. Giaccia1
Metastasis is a multistep process responsible for most cancer deaths, and it can be influenced by both the immediate microenvironment (cell–cell or cell–matrix interactions) and the extended tumour microenvironment (for example vascularization)1. Hypoxia (low oxygen) is clinically associated with metastasis and poor patient outcome, although the underlying processes remain unclear2. Microarray studies have shown the expression of lysyl oxidase (LOX) to be elevated in hypoxic human tumour cells3. Paradoxically, LOX expression is associated with both tumour suppression and tumour progression, and its role in tumorigenesis seems dependent on cellular location, cell type and transformation status4, 5, 6, 7, 8, 9. Here we show that LOX expression is regulated by hypoxia-inducible factor (HIF) and is associated with hypoxia in human breast and head and neck tumours. Patients with high LOX-expressing tumours have poor distant metastasis-free and overall survivals. Inhibition of LOX eliminates metastasis in mice with orthotopically grown breast cancer tumours. Mechanistically, secreted LOX is responsible for the invasive properties of hypoxic human cancer cells through focal adhesion kinase activity and cell to matrix adhesion. Furthermore, LOX may be required to create a niche permissive for metastatic growth. Our findings indicate that LOX is essential for hypoxia-induced metastasis and is a good therapeutic target for preventing and treating metastases.
- Department of Radiation Oncology,
- Department of Surgery,
- Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA
- Department of Obstetrics and Gynecology, University of Leipzig, Leipzig 04103, Germany
- Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina 27708, USA
Correspondence to: Amato J. Giaccia1 Correspondence and requests for materials should be addressed to A.J.G. (Email: giaccia@stanford.edu).
Received 13 January 2006 | Accepted 2 March 2006
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesisModern Pathology Original Article
Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo ? use of the human tyrosinase promoter with human enhancersCancer Gene Therapy Original Article
See all 15 matches for Research